A study shows good outcomes for office-based retinal surgeries typically done in a hospital or ambulatory surgery center, but their complexity may be an open question. Medscape Medical News
Uncategorized
Myopia control ‘twice as fast’ with Essilor Stellest 2.0 lenses
Children wearing Essilor Stellest 2.0 lenses for 6 months had reductions in myopia progression comparable to changes in children who wore the original version of the glasses for a year, according to a press release from EssilorLuxottica.“The treatment …
Uncategorized
STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results a…
Uncategorized
Alcon acquires Neurotech Pharmaceuticals
Alcon has acquired Neurotech Pharmaceuticals and Encelto, its macular telangiectasia type 2 therapy, according to a press release.Alcon paid $550 million in the acquisition of Neurotech and could make contingent payments based on commercial milestones,…
Uncategorized
Phase 2 clinical trial of EC-104 for DME meets primary endpoint
A phase 2 clinical trial investigating EC-104, a fluocinolone acetonide extended-release intravitreal implant for the treatment of diabetic macular edema, met its primary endpoint, according to a press release from Eclipse Life Sciences.As Healio previ…
A1c: Not as Useful in Practice as One Might Think
Ms Said and Dr Paauw explain several drawbacks of use of A1c in practice. Medscape Internal Medicine